Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Antibiotic Minimal Selective Concentrations and Fitness Costs during Biofilm and Planktonic Growth
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Biochemistry and Microbiology.ORCID iD: 0000-0003-3326-8495
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Biochemistry and Microbiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Biochemistry and Microbiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.ORCID iD: 0000-0001-5642-0360
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Biochemistry and Microbiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences.ORCID iD: 0000-0001-6640-2174
2022 (English)In: mBio, ISSN 2161-2129, E-ISSN 2150-7511, Vol. 13, no 3Article in journal (Refereed) Published
Abstract [en]

The use and misuse of antibiotics have resulted in the selection of difficult-to-treat resistant bacteria. Two key parameters that influence the selection of resistant bacteria are the minimal selective concentration (MSC) and the fitness cost of resistance, both of which have been measured during planktonic growth in several studies. However, bacterial growth most often occurs in biofilms, and it is unclear if and how these parameters differ under these two growth conditions. To address this knowledge gap, we compared a selection of several types of antibiotic-resistant Escherichia coli mutants during planktonic and biofilm growth to determine the fitness costs and MSCs. Biofilm-forming Escherichia coli strains are commonly found in catheter-associated and recurrent urinary tract infections. Isogenic strains of a biofilm-forming E. coli strain, differing only in the resistance mechanisms and the fluorescent markers, were constructed, and susceptible and resistant bacteria were grown in head-to-head competitions at various concentrations of antibiotics under planktonic and biofilm conditions. Mutants with resistance to five different antibiotics were studied. The results show that during both planktonic and biofilm growth, selection for the resistant mutants occurred for all antibiotics at sub-MICs far below the MIC of the antibiotic. Even though differences were seen, the MSC values and the fitness costs did not differ systematically between planktonic and biofilm growth, implying that despite the different growth modes, the basic selection parameters are similar. These findings highlight the risk that resistant mutants may, similarly to planktonic growth, also be selected at sub-MICs of antibiotics in biofilms.

IMPORTANCE Our understanding of how and where antibiotic resistance is selected in response to antibiotic exposure is still limited, and this is particularly true for selective processes when bacteria are growing in biofilms, arguably the most significant mode of growth of bacteria in human and animal infections as well as in other settings. In this study, we compared how different types of resistant E. coli strains were selected in response to antibiotic exposure during planktonic and biofilm growth. Determination of the minimal selective concentrations (MSCs) and fitness costs of resistance showed that they were comparable under these two different conditions, even though some differences were observed. Importantly, the MSCs were far below the MICs for all mutants under both planktonic and biofilm growth, emphasizing the significance of low antibiotic concentrations in driving the emergence and enrichment of resistant bacteria. Our understanding of how and where antibiotic resistance is selected in response to antibiotic exposure is still limited, and this is particularly true for selective processes when bacteria are growing in biofilms, arguably the most significant mode of growth of bacteria in human and animal infections as well as in other settings. In this study, we compared how different types of resistant E. coli strains were selected in response to antibiotic exposure during planktonic and biofilm growth.

Place, publisher, year, edition, pages
AMER SOC MICROBIOLOGY American Society for Microbiology, 2022. Vol. 13, no 3
Keywords [en]
Escherichia coli, antibiotic resistance, biofilms, fitness, minimal selective concentration, planktonic
National Category
Microbiology
Identifiers
URN: urn:nbn:se:uu:diva-483058DOI: 10.1128/mbio.01447-22ISI: 000811802400004PubMedID: 35695458OAI: oai:DiVA.org:uu-483058DiVA, id: diva2:1694423
Available from: 2022-09-09 Created: 2022-09-09 Last updated: 2024-01-15Bibliographically approved
In thesis
1. Antibiotic interactions and selection for resistance in biofilms
Open this publication in new window or tab >>Antibiotic interactions and selection for resistance in biofilms
2023 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

The challenges posed by antibiotic-resistant bacteria in treating infections, particularly those associated with biofilms, require a deeper understanding of this lifestyle and its connection to resistance selection. Additionally, gaining insights into drug interactions is crucial for enhancing combination treatment efficacy and mitigating resistance development. This thesis is divided into these two main themes, each consisting of individual papers with specific objectives and aims that tackle these two themes.

The first introduces a proof-of-concept microfluidic chip named Brimor, which demonstrates the selection of ciprofloxacin-resistant mutants in Escherichia coli biofilms at concentrations below the minimum inhibitory concentration (sub-MIC). Brimor exhibits potential applications beyond antibiotics and bacteria.

The second explores the emergence of resistance in both planktonic and biofilm lifestyles. Using the FlexiPeg model and uropathogenic E. coli, the fitness cost and minimal selective concentrations were assessed for five antibiotics and six resistance-conferring mutations during biofilm and planktonic growth. This analysis revealed resistance development in both lifestyles at sub-MIC.

Furthermore, an assay called CombiANT® was developed and validated with three major pathogens, enabling simple quantification and subsequent categorization of antibiotic interactions. This assay demonstrated comparable performance to the gold-standard checkerboard and time-kill assays. CombiANT® also shows potential for applications beyond antibiotics and bacteria.

Isolate-specific interaction profiling was emphasized as crucial among five important Gram-negative pathogens for achieving precise and effective combination therapy. Interactions of clinically used antibiotic combinations varied significantly between and within susceptible species, with additive and antagonistic interactions being the most common. Only a small percentage exhibited clinically relevant synergy.

The mutations associated with synergy and loss of synergy for the tetracycline and spectinomycin combination in E. coli was elucidated. Genetic changes associated with efflux regulation and metabolic pathways were identified as factors contributing to the loss of synergy in mutants. The bioavailability model was the prevailing mechanism of action accounting for synergy and loss of synergy for the combination.

In summary, the papers presented in this thesis provide valuable insights on antibiotic resistance selection in biofilms, antibiotic interactions, and the development of innovative tools for studying biofilms and combination therapies. Further understanding of these factors is necessary for applying these findings in clinical settings and to optimize combination strategies for effective personalized therapy and antibiotic stewardship.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2023. p. 45
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 1960
Keywords
antibiotics
National Category
Microbiology Microbiology in the medical area
Research subject
Microbiology
Identifiers
urn:nbn:se:uu:diva-502088 (URN)978-91-513-1853-0 (ISBN)
Public defence
2023-09-29, Svedbergsalen, BMC, Husargatan 3, Uppsala, 09:00 (English)
Opponent
Supervisors
Available from: 2023-08-28 Created: 2023-07-24 Last updated: 2023-08-28

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedTo the article

Authority records

Hjort, KarinTang, Po-ChengAndersson, Dan I.

Search in DiVA

By author/editor
Hjort, KarinFermer, ElinTang, Po-ChengAndersson, Dan I.
By organisation
Department of Medical Biochemistry and MicrobiologyDepartment of Medical SciencesDepartment of Medical Cell BiologyDepartment of Public Health and Caring Sciences
In the same journal
mBio
Microbiology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 348 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf